Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
Consulting agrmnt
|
|
ClearPoint Neuro, Inc. (CLPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2023 |
4
| D'Alessandro Danilo (CFO) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Paid exercise price by delivering 4,958 shares
@ $5.01, valued at
$24.8k
|
|
| 10/03/2023 |
4
| Richards Timothy T. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 2,226 shares
@ $5.01, valued at
$11.2k
|
|
| 10/03/2023 |
4
| FLETCHER R JOHN (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 1,153 shares
@ $5.01, valued at
$5.8k
|
|
| 10/03/2023 |
4
| Girin Pascal E R (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 1,434 shares
@ $5.01, valued at
$7.2k
|
|
| 08/22/2023 |
4
| D'Alessandro Danilo (CFO) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Paid exercise price by delivering 1,166 shares
@ $5.34, valued at
$6.2k
|
|
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
4
| STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Paid exercise price by delivering 1,730 shares
@ $6.53, valued at
$11.3k
|
|
| 07/05/2023 |
4
| BURNETT JOSEPH MICHAEL (CEO and President) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 2,095 shares
@ $6.15, valued at
$12.9k
|
|
| 07/05/2023 |
4
| STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 2,682 shares
@ $6.15, valued at
$16.5k
|
|
| 07/05/2023 |
4
| SABRA MAZIN (COO) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 552 shares
@ $6.15, valued at
$3.4k
|
|
| 07/05/2023 |
4
| D'Alessandro Danilo (CFO) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 1,371 shares
@ $6.15, valued at
$8.4k
|
|
| 07/05/2023 |
4
| FLETCHER R JOHN (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 798 shares
@ $7.24, valued at
$5.8k
|
|
| 07/05/2023 |
4
| Richards Timothy T. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 1,540 shares
@ $7.24, valued at
$11.1k
|
|
| 07/05/2023 |
4
| Girin Pascal E R (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 992 shares
@ $7.24, valued at
$7.2k
|
|
| 05/26/2023 |
4
| Girin Pascal E R (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| Richards Timothy T. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| Klein Matthew B. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| FLETCHER R JOHN (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| LIAU LINDA M. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| FALLON LYNNETTE C (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| JOHNSON B KRISTINE (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/25/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 04/14/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/04/2023 |
4
| Richards Timothy T. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 1,321 shares
@ $8.44, valued at
$11.1k
|
|
| 04/04/2023 |
4
| FLETCHER R JOHN (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 684 shares
@ $8.44, valued at
$5.8k
|
|
| 04/04/2023 |
4
| Girin Pascal E R (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 851 shares
@ $8.44, valued at
$7.2k
|
|
| 04/03/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/08/2023 |
4
| BURNETT JOSEPH MICHAEL (CEO and President) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 39,506 options to buy
@ $8.1, valued at
$320k
Granted 118,518 restricted stock units
@ $0 |
|
|
|
|